Dechra Pharmaceuticals PLC (DPH.L) LSE

3,866.00

+2(+0.05%)

Updated at January 15, 2024 05:38PM

Currency In GBp

Valuation

Market Cap4.18B
Enterprise Value4.61B
P/E Ratio-157.24
PEG Ratio-1.57
Price/Sales Ratio5.78
Price/Book Ratio5.81
Enterprise/Revenue6.35
Enterprise/EBITDA49.27

Fiscal Year

Fiscal YearJune 30, 2023
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin-0.04
Operating Margin0.01

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue761.5M
Revenue/Share6.71
Gross Profit426.3M
EBITDA98.1M
Net Income-27.9M
Diluted EPS-0.24

Balance Sheet

Total Cash74.4M
Total Cash/Share0.66
Total Debt504.5M
Total Debt/Equity0.67
Current Ratio2.85
Book Value Per Share6.66

Price History

52-Week Change27.76
52-Week High4,145.84
52-Week Low0
Moving Average 50 Days3,828.32
Moving Average 200 Days3,700.25

Statistics

Average Volume1.36M
Shares Outstanding113.91M
% Held by Institutions0.12

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.85
Last Split FactorN/A
Last Split DateN/A